We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

216 hedge funds and large institutions have $3.72B invested in Maravai LifeSciences in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 92 increasing their positions, 76 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $6.21M | Put options by funds: $2.65M

21% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 76

2.41% more ownership

Funds ownership: 97.31% → 99.72% (+2.4%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less funds holding

Funds holding: 235 → 216 (-19)

17% less capital invested

Capital invested by funds: $4.51B → $3.72B (-$789M)

41% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 39

Holders
216
Holders Change
-19
Holders Change %
-8.09%
% of All Funds
3.64%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
92
Reduced
76
Closed
39
Calls
$6.21M
Puts
$2.65M
Net Calls
+$3.56M
Net Calls Change
-$7.32M

Top Buyers

Rank Fund Capital Flow
1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$118M
2
American Century Companies
American Century Companies
Missouri
+$75.9M
3
Renaissance Technologies
Renaissance Technologies
New York
+$30.5M
4
AIM
Artemis Investment Management
United Kingdom
+$29.1M
5
Prudential Financial
Prudential Financial
New Jersey
+$23.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$172M
2
CIP
Champlain Investment Partners
Vermont
-$36.8M
3
N
Natixis
France
-$35.3M
4
Millennium Management
Millennium Management
New York
-$17.6M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$12.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
101
VOYA Investment Management
Georgia
$1.34M -$203K -6,397 -12%
Manulife (Manufacturers Life Insurance)
102
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.32M -$254K -8,028 -14%
LOAME
103
Lombard Odier Asset Management (Europe)
United Kingdom
$1.28M +$1.43M +45,000 New
DekaBank Deutsche Girozentrale
104
DekaBank Deutsche Girozentrale
Germany
$1.22M – – –
Bank of Nova Scotia
105
Bank of Nova Scotia
Ontario, Canada
$1.19M +$1.33M +42,106 New
GH
106
GAM Holding
Switzerland
$1.19M +$443K +13,998 +50%
Jane Street
107
Jane Street
New York
$1.1M -$2.03M -64,039 -62%
GT
108
Glenmede Trust
Pennsylvania
$1.08M +$1.2M +37,974 New
Federated Hermes
109
Federated Hermes
Pennsylvania
$1.03M +$1.14M +36,036 +9,819%
Nomura Asset Management
110
Nomura Asset Management
Japan
$1.02M +$1.13M +35,759 New
CAPTRUST Financial Advisors
111
CAPTRUST Financial Advisors
North Carolina
$994K +$45.6K +1,438 +4%
Ensign Peak Advisors
112
Ensign Peak Advisors
Utah
$978K – – –
Verition Fund Management
113
Verition Fund Management
Connecticut
$916K +$191K +6,020 +23%
PC
114
Pier Capital
Connecticut
$898K +$388K +12,244 +63%
Bessemer Group
115
Bessemer Group
New Jersey
$876K – – –
ASRS
116
Arizona State Retirement System
Arizona
$860K +$2.44K +77 +0.3%
Wells Fargo
117
Wells Fargo
California
$801K -$1.08M -34,130 -55%
DCM
118
Dupont Capital Management
Delaware
$790K +$74.6K +2,354 +9%
EAM
119
Erste Asset Management
Austria
$790K – – –
Cerity Partners
120
Cerity Partners
New York
$743K +$65.1K +2,055 +9%
GCM
121
Graham Capital Management
Connecticut
$737K -$822K -25,964 -50%
AB
122
Amalgamated Bank
New York
$698K -$23.9K -753 -3%
ACM
123
ACT Capital Management
Pennsylvania
$696K +$776K +24,500 New
Victory Capital Management
124
Victory Capital Management
Texas
$664K -$4.34K -137 -0.6%
ECM
125
Endurant Capital Management
California
$654K +$729K +23,015 New
3 4
5
6 7

MRVI Hedge Fund Activity: Q2 2022 in Review

216 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q2 2022, worth a combined $3.72B — down 17% from $4.51B a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of MRVI and 23 opened new positions — a net loss of 16 holders — while 76 trimmed existing stakes and 92 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $118M. The largest seller was Fidelity Investments, cutting an estimated $172M.

  • 216 institutional investors held Maravai LifeSciences (MRVI) as of Q2 2022, down from 235 in Q1 2022.
  • Funds reported $3.72B of Maravai LifeSciences stock for Q2 2022, down 17% quarter-over-quarter.
  • 23 funds opened new Maravai LifeSciences positions in Q2 2022 and 39 closed out, a net change of -16 holders.
  • The largest Maravai LifeSciences buyer in Q2 2022 was Massachusetts Financial Services, an estimated $118M added.
  • The largest Maravai LifeSciences seller in Q2 2022 was Fidelity Investments, an estimated $172M sold.

Based on aggregated 13F filings for Q2 2022.